These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27151373)

  • 21. Ondansetron Use in Pregnancy and Birth Defects: A Systematic Review.
    Carstairs SD
    Obstet Gynecol; 2016 May; 127(5):878-883. PubMed ID: 27054939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Major Congenital Malformation Risk After First Trimester Gestational Exposure to Oral or Intravenous Ondansetron.
    Andrade C
    J Clin Psychiatry; 2020 Jun; 81(3):. PubMed ID: 32526103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metoclopramide and diphenhydramine in the treatment of hyperemesis gravidarum: effectiveness and predictors of rehospitalisation.
    Lacasse A; Lagoutte A; Ferreira E; Bérard A
    Eur J Obstet Gynecol Reprod Biol; 2009 Mar; 143(1):43-9. PubMed ID: 19135291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ondansetrone or metoclopromide? Which is more effective in severe nausea and vomiting of pregnancy? A randomized trial double-blind study.
    Kashifard M; Basirat Z; Kashifard M; Golsorkhtabar-Amiri M; Moghaddamnia A
    Clin Exp Obstet Gynecol; 2013; 40(1):127-30. PubMed ID: 23724526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaining Insight Into Ondansetron Safety in Early Pregnancy.
    Lavecchia M; Chari R; Ross S
    J Obstet Gynaecol Can; 2019 Apr; 41(4):419-420. PubMed ID: 30685231
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of discharge treatment prescribed to women admitted to hospital for hyperemesis gravidarum.
    Fiaschi L; Housley G; Nelson-Piercy C; Gibson J; Raji A; Deb S; Tata LJ
    Int J Clin Pract; 2019 Jan; 73(1):e13261. PubMed ID: 30239072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of ondansetron during pregnancy and the risk of major congenital malformations: A systematic review and meta-analysis.
    Kaplan YC; Richardson JL; Keskin-Arslan E; Erol-Coskun H; Kennedy D
    Reprod Toxicol; 2019 Jun; 86():1-13. PubMed ID: 30849498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperemesis gravidarum and pregnancy outcomes].
    Hastoy A; Lien Tran P; Lakestani O; Barau G; Gérardin P; Boukerrou M
    J Gynecol Obstet Biol Reprod (Paris); 2015 Feb; 44(2):154-63. PubMed ID: 24440130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum.
    Koren G; Maltepe C
    J Obstet Gynaecol; 2004 Aug; 24(5):530-3. PubMed ID: 15369934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.
    Taylor LG; Bird ST; Sahin L; Tassinari MS; Greene P; Reichman ME; Andrade SE; Haffenreffer K; Toh S
    Pharmacoepidemiol Drug Saf; 2017 May; 26(5):592-596. PubMed ID: 28220993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Publishing negative findings and the challenge of avoiding type II errors in studies of suspect teratogens: Example of a recent ondansetron publication.
    Edlavitch SA
    Reprod Toxicol; 2017 Jan; 67():125-128. PubMed ID: 27988282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hyperemesis gravidarum].
    Koot MH; Grooten IJ; Gauw NE; Roseboom TJ; Painter RC
    Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ondansetron should never be used in pregnancy: Against: Ondansetron in pregnancy revisited.
    Damkier P; Kaplan YC; Shechtman S; Diav-Citrin O; Cassina M; Weber-Schoendorfer C; Cleary B; Hodson K
    BJOG; 2021 Jan; 128(1):111-112. PubMed ID: 32991063
    [No Abstract]   [Full Text] [Related]  

  • 34. Ondansetron and hyperemesis gravidarum.
    Guikontes E; Spantideas A; Diakakis J
    Lancet; 1992 Nov; 340(8829):1223. PubMed ID: 1359289
    [No Abstract]   [Full Text] [Related]  

  • 35. Ondansetron and hyperemesis gravidarum.
    World MJ
    Lancet; 1993 Jan; 341(8838):185. PubMed ID: 8093793
    [No Abstract]   [Full Text] [Related]  

  • 36. History of depression and risk of hyperemesis gravidarum: a population-based cohort study.
    Kjeldgaard HK; Eberhard-Gran M; Benth JŠ; Nordeng H; Vikanes ÅV
    Arch Womens Ment Health; 2017 Jun; 20(3):397-404. PubMed ID: 28064341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC): A Randomized, Controlled Trial.
    Moussa G; Genest M; Villeneuve E; Wang JJ
    Ann Emerg Med; 2021 May; 77(5):555. PubMed ID: 33902836
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperemesis Gravidarum: Strategies to Improve Outcomes.
    MacGibbon KW
    J Infus Nurs; 2020; 43(2):78-96. PubMed ID: 32106195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety considerations surrounding use of treatment options for nausea and vomiting in pregnancy.
    Koren G
    Expert Opin Drug Saf; 2017 Nov; 16(11):1227-1234. PubMed ID: 28749713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnant women report being denied medications to treat severe nausea and vomiting of pregnancy or hyperemesis gravidarum - findings from an Australian online survey.
    Hsiao HF; Thomas A; Kay-Smith C; Grzeskowiak LE
    Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):616-620. PubMed ID: 33984156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.